{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:02:36Z","timestamp":1790265756584,"version":"4.1.0"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.pnpbp.2017.10.004","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T14:38:39Z","timestamp":1507819119000},"page":"38-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["DNA methylation and antipsychotic treatment mechanisms in schizophrenia: Progress and future directions"],"prefix":"10.1016","volume":"81","author":[{"given":"Ellen S.","family":"Ovenden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel W.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin A.","family":"Emsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Warnich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2017.10.004_bb0005","first-page":"1","article-title":"Horizons of psychiatric genetics and epigenetics: where are we and where are we heading?","volume":"8","author":"Abdolmaleky","year":"2014","journal-title":"Iran. J. Psychiatry Behav. Sci."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ajmg.b.30140","article-title":"Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report","volume":"134B","author":"Abdolmaleky","year":"2005","journal-title":"Am. J. Med. Genet. Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0020","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1093\/hmg\/ddl253","article-title":"Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder","volume":"15","author":"Abdolmaleky","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0030","series-title":"Reelin Glycoprotein: Structure, Biology and Roles in Health and Disease","first-page":"365","article-title":"Epigenetic modulation of reelin function in schizophrenia and bipolar disorder","author":"Abdolmaleky","year":"2008"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0040","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.schres.2011.04.007","article-title":"Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder","volume":"129","author":"Abdolmaleky","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.schres.2013.12.007","article-title":"DNA hypermethylation of serotonin transporter gene promoter in drug na\u00efve patients with schizophrenia","volume":"152","author":"Abdolmaleky","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ajmg.b.32361","article-title":"Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and psychotic bipolar disorder","volume":"168","author":"Abdolmaleky","year":"2015","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/496416a","article-title":"On the spectrum","volume":"496","author":"Adam","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0065","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archpsyc.1995.03950160008002","article-title":"Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics","volume":"52","author":"Akbarian","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0070","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/nn.4156","article-title":"The PsychENCODE project","volume":"18","author":"Akbarian","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0075","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.mp.4002009","article-title":"Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research","volume":"12","author":"Arranz","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0080","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s40473-016-0083-4","article-title":"Epigenetic research in neuropsychiatric disorders: the \u201cTissue Issue\u201d","volume":"3","author":"Bakulski","year":"2016","journal-title":"Curr. Behav. Neurosci. Rep."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0085","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/dyr179","article-title":"The value of twins in epigenetic epidemiology","volume":"41","author":"Bell","year":"2012","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0090","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/nbt1010-1045","article-title":"The NIH roadmap epigenomics mapping consortium","volume":"28","author":"Bernstein","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0095","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature05913","article-title":"Perceptions of epigenetics","volume":"447","author":"Bird","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.psychres.2011.09.004","article-title":"Methylation matters? Decreased methylation status of genomic DNA in the blood of schizophrenic twins","volume":"198","author":"B\u00f6nsch","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0105","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.neuron.2008.10.012","article-title":"Decoding the epigenetic language of neuronal plasticity","volume":"60","author":"Borrelli","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0110","doi-asserted-by":"crossref","first-page":"852930","DOI":"10.1155\/2013\/852930","article-title":"Negative symptoms of psychosis correlate with gene expression of the Wnt\/beta-catenin signaling pathway in peripheral blood","volume":"2013","author":"Bousman","year":"2013","journal-title":"Psychiatry J."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/070674371405900203","article-title":"Pharmacogenetics of antipsychotics","volume":"59","author":"Brandl","year":"2014","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0120","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.biopsych.2004.12.002","article-title":"Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions","volume":"57","author":"Browning","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/bdi.12422","article-title":"Gene-specific DNA methylation may mediate atypical antipsychotic-induced insulin resistance","volume":"18","author":"Burghardt","year":"2016","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.0.CO;2-U","article-title":"Twin studies of schizophrenia: from bow-and-arrow concordances to Star Wars Mx and functional genomics","volume":"97","author":"Cardno","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0135","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jad.2011.03.018","article-title":"Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder","volume":"132","author":"Carrard","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/FPC.0b013e32835ca260","article-title":"Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment","volume":"23","author":"Clark","year":"2013","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0145","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10524","article-title":"Temporal dynamics and genetic control of transcription in the human prefrontal cortex","volume":"478","author":"Colantuoni","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1471-4892(01)00121-7","article-title":"The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics","volume":"2","author":"Costa","year":"2002","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YPG.0b013e32835d7e5a","article-title":"Consideration of plausible genetic architectures for schizophrenia and implications for analytic approaches in the era of next generation sequencing","volume":"23","author":"Curtis","year":"2013","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0160","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2012-13-6-r43","article-title":"Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood","volume":"13","author":"Davies","year":"2012","journal-title":"Genome Biol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.phrs.2008.10.002","article-title":"The future (or lack of future) of personalized prescription in psychiatry","volume":"59","author":"De Leon","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0170","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/0269881112449396","article-title":"Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model","volume":"26","author":"Deng","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0175","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/embor.2011.110","article-title":"Regulation of mammalian DNA methyltransferases: a route to new mechanisms","volume":"12","author":"Denis","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0180","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1017\/S146114571400039X","article-title":"Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response","volume":"17","author":"Domschke","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0185","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1073\/pnas.0805493105","article-title":"Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation","volume":"105","author":"Dong","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0190","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1038\/tp.2012.86","article-title":"Upregulation of TET1 and downregulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients","volume":"2","author":"Dong","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0195","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1038\/tp.2015.191","article-title":"Behavioral and molecular neuroepigenetic alterations in prenatally stressed mice: relevance for the study of chromatin remodeling properties of antipsychotic drugs","volume":"6","author":"Dong","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0200","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/FPC.0000000000000213","article-title":"The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients","volume":"26","author":"Dr\u00f6gem\u00f6ller","year":"2016","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S003329171200089X","article-title":"Gender difference in age at onset of schizophrenia: a meta-analysis","volume":"43","author":"Eranti","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0210","first-page":"793","article-title":"Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia","volume":"59","author":"Esteller","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0215","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200011093431901","article-title":"Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents","volume":"343","author":"Esteller","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0220","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.celrep.2015.02.001","article-title":"Single-cell DNA Methylome sequencing and bioinformatic inference of epigenomic cell-state dynamics","volume":"10","author":"Farlik","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pnpbp.2015.02.001","article-title":"Imipramine protects against the deleterious effects of chronic corticosterone on depression-like behavior, hippocampal reelin expression, and neuronal maturation","volume":"60","author":"Fenton","year":"2015","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0230","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/10673220701551136","article-title":"The role of one-carbon metabolism in schizophrenia and depression","volume":"15","author":"Frankenburg","year":"2007","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0235","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1073\/pnas.062066299","article-title":"A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status","volume":"99","author":"Friso","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0240","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0245","first-page":"9","article-title":"Transcriptome alterations in the prefrontal cortex of subjects with schizophrenia who committed suicide","volume":"10","author":"Garbett","year":"2008","journal-title":"Neuropsychopharmacol. Hung."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0250","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ajmg.b.31192","article-title":"Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder","volume":"156","author":"Ghadirivasfi","year":"2011","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0255","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.neuropharm.2011.05.011","article-title":"Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia","volume":"62","author":"Grace","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0260","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/sj.mp.4002062","article-title":"The pipeline and future of drug development in schizophrenia","volume":"12","author":"Gray","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0265","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/npp.2012.125","article-title":"The dynamics of DNA methylation in schizophrenia and related psychiatric disorders","volume":"38","author":"Grayson","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0270","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4161\/epi.4.3.8534","article-title":"From trans-methylation to cytosine methylation: Evolution of the methylation hypothesis of schizophrenia","volume":"4","author":"Grayson","year":"2009","journal-title":"Epigenetics"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0275","doi-asserted-by":"crossref","first-page":"e29630","DOI":"10.1371\/journal.pone.0029630","article-title":"Association analysis of 94 candidate genes and schizophrenia-related endophenotypes","volume":"7","author":"Greenwood","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0280","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","article-title":"Decrease in reelin and glutamic acid decarboxylase 67 (GAD 67) expression in schizophrenia and bipolar disorder","volume":"57","author":"Guidotti","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0285","doi-asserted-by":"crossref","DOI":"10.4161\/epi.23924","article-title":"A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression","volume":"8","author":"Guintivano","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0290","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0306-4530(02)00125-7","article-title":"Gender differences in schizophrenia","volume":"28","author":"H\u00e4fner","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0295","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1080\/15592294.2015.1100786","article-title":"Interindividual methylomic variation across blood, cortex, and cerebellum: implications for epigenetic studies of neurological and neuropsychiatric phenotypes","volume":"10","author":"Hannon","year":"2015","journal-title":"Epigenetics"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0300","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13059-016-1041-x","article-title":"An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation","volume":"17","author":"Hannon","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0305","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nn.4182","article-title":"Methylation quantitative trait loci in the developing brain and their enrichment in schizophrenia-associated genomic regions","volume":"19","author":"Hannon","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0310","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.mp.4002011","article-title":"Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia","volume":"13","author":"Hashimoto","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0315","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1128\/MCB.18.11.6538","article-title":"Identification and characterization of a family of mammalian methyl-CpG binding proteins","volume":"18","author":"Hendrich","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0320","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/clinchem\/48.10.1819","article-title":"The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford","volume":"48","author":"Herzenberg","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0325","doi-asserted-by":"crossref","first-page":"9362","DOI":"10.1073\/pnas.0903103106","article-title":"Potential etiologic and functional implications of genome-wide association loci for human diseases and traits","volume":"106","author":"Hindorff","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0330","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2012-13-10-r97","article-title":"Aging effects on DNA methylation modules in human brain and blood tissue","volume":"13","author":"Horvath","year":"2012","journal-title":"Genome Biol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0335","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.biochi.2012.07.014","article-title":"DNA methylation based biomarkers: practical considerations and applications","volume":"94","author":"How Kit","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0340","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment","volume":"69","author":"Howes","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0345","doi-asserted-by":"crossref","first-page":"e809","DOI":"10.1371\/journal.pone.0000809","article-title":"GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia","volume":"2","author":"Huang","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0350","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/jhg.2013.65","article-title":"DNA methylation of the BDNF gene and its relevance to psychiatric disorders","volume":"58","author":"Ikegame","year":"2013","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0355","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.1210597","article-title":"Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine","volume":"333","author":"Ito","year":"2011","journal-title":"Science (80-.)"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0360","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tips.2014.05.004","article-title":"Epigenetic mechanisms of importance for drug treatment","volume":"35","author":"Ivanov","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0365","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2011.05.008","article-title":"Repeated citalopram administration counteracts kainic acid-induced spreading of PSA-NCAM-immunoreactive cells and loss of reelin in the adult mouse hippocampus","volume":"666","author":"Jaako","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl","key":"10.1016\/j.pnpbp.2017.10.004_bb0370","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng1089","article-title":"Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals","volume":"33","author":"Jaenisch","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0375","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nn.4181","article-title":"Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex","volume":"19","author":"Jaffe","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0380","first-page":"468","article-title":"Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification","volume":"12","author":"Javitt","year":"2009","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0385","series-title":"Association Between the Methylenetetrahydrofolate Reductase 677C\u2192T Missense Mutation and schizophrenia","first-page":"323","author":"Joober","year":"2000"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0390","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.schres.2008.09.015","article-title":"Evidence for positive selection on Protocadherin Y gene in Homo sapiens: implications for schizophrenia","volume":"108","author":"Kalmady","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0395","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/19.2.261","article-title":"The genetics of schizophrenia; a current genetic \u2013 epidermiologic perspective","volume":"19","author":"Kendler","year":"1993","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0400","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biopsych.2010.10.032","article-title":"Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains","volume":"69","author":"Kleinman","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0405","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13148-016-0256-8","article-title":"DNA methylation: conducting the orchestra from exposure to phenotype?","volume":"8","author":"Leenen","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0410","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0415","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/pr.107.00107","article-title":"Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection","volume":"60","author":"Lieberman","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0420","doi-asserted-by":"crossref","first-page":"e33598","DOI":"10.1371\/journal.pone.0033598","article-title":"Genome-wide association study of treatment refractory schizophrenia in Han Chinese","volume":"7","author":"Liou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2016.12.071","article-title":"DNA Methylation and Clinical Response to Antidepressant Medication in Major Depressive Disorder: a Review and Recommendations","author":"Lisoway","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0430","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/14656560903508762","article-title":"Pharmacogenetic considerations in the treatment of psychiatric disorders","volume":"11","author":"Lohoff","year":"2010","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0435","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/epi.24362","article-title":"Buccals are likely to be a more informative surrogate tissue than blood for epigenome-wide association studies","volume":"8","author":"Lowe","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0440","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.neuropharm.2010.09.007","article-title":"Reelin as a putative vulnerability factor for depression: Examining the depressogenic effects of repeated corticosterone in heterozygous reeler mice","volume":"60","author":"Lussier","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0445","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuropharm.2013.04.012","article-title":"The progressive development of depression-like behavior in corticosterone-treated rats is paralleled by slowed granule cell maturation and decreased reelin expression in the adult dentate gyrus","volume":"71","author":"Lussier","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0450","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3233\/JAD-2010-1289","article-title":"The CST3 BB genotype and low cystatin C cerebrospinal fluid levels are associated with dementia in lewy body disease","volume":"19","author":"Maetzler","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0455","doi-asserted-by":"crossref","first-page":"e31901","DOI":"10.1371\/journal.pone.0031901","article-title":"Transgenerational actions of environmental compounds on reproductive disease and identification of epigenetic biomarkers of ancestral exposures","volume":"7","author":"Manikkam","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0460","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/264363a0","article-title":"The effects of antipsychotics on the turnover rate of GABA and acetylcholine in rat brain nuclei","volume":"264","author":"Marco","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0465","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ddr.21337","article-title":"Improving current treatments for schizophrenia","volume":"77","author":"Maric","year":"2016","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0470","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuropharm.2012.04.013","article-title":"Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice","volume":"68","author":"Matrisciano","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0475","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1222794","article-title":"Systematic localization of common disease-associated variation in regulatory DNA","volume":"337","author":"Maurano","year":"2012","journal-title":"Science (80-.)"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0480","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/mp.2009.89","article-title":"Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics","volume":"16","author":"McClay","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0485","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/npp.2010.193","article-title":"Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia","volume":"36","author":"McClay","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0490","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.biopsych.2010.09.035","article-title":"Novel approaches to the study of postmortem brain in psychiatric illness: old limitations and new challenges","volume":"69","author":"McCullumsmith","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0495","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13059-016-0935-y","article-title":"An evaluation of methods correcting for cell-type heterogeneity in DNA methylation studies","volume":"17","author":"McGregor","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0500","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1242\/jcs.1992.Supplement_16.2","article-title":"Transcriptional repression by methylation of CpG","volume":"1992","author":"Meehan","year":"1992","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0505","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.pneurobio.2008.10.001","article-title":"Epigenetic principles and mechanisms underlying nervous system functions in health and disease","volume":"86","author":"Mehler","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0510","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1096\/fj.11-202069","article-title":"Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset","volume":"26","author":"Melas","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0515","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2049-9256-1-19","article-title":"Olanzapine induced DNA methylation changes support the dopamine hypothesis of psychosis","volume":"1","author":"Melka","year":"2013","journal-title":"J. Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0520","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2202-15-112","article-title":"Olanzapine-induced methylation alters cadherin gene families and associated pathways implicated in psychosis","volume":"15","author":"Melka","year":"2014","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.10.004_bb0525","doi-asserted-by":"crossref","DOI":"10.1186\/1868-7083-6-1","article-title":"The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum","volume":"6","author":"Melka","year":"2014","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0530","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0535","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ajhg.2008.01.008","article-title":"Epigenomic profiling reveals DNA-methylation changes associated with major psychosis","volume":"82","author":"Mill","year":"2008","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0540","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpsychires.2014.03.021","article-title":"Humanistic burden in schizophrenia: a literature review","volume":"54C","author":"Millier","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0545","first-page":"236","article-title":"Association of DNA methylation of Taq1A in the DRD2 with response to aripiprazole in acute schizophrenia","volume":"19","author":"Miura","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0550","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0555","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/gb-2013-14-8-r94","article-title":"Measuring cell-type specific differential methylation in human brain tissue","volume":"14","author":"Monta\u00f1o","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0560","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/YCO.0b013e32835dc9da","article-title":"The pharmacogenetics of antipsychotic-induced adverse events","volume":"26","author":"M\u00fcller","year":"2013","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0565","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neulet.2014.01.038","article-title":"Comprehensive DNA methylation analysis of human neuroblastoma cells treated with blonanserin","volume":"563","author":"Murata","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0570","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ceb.2007.02.016","article-title":"Signaling to the circadian clock: plasticity by chromatin remodeling","volume":"19","author":"Nakahata","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0575","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1089\/omi.2016.0041","article-title":"Epigenomics of Total acute sleep deprivation in relation to genome-wide DNA methylation profiles and RNA expression","volume":"20","author":"Nilsson","year":"2016","journal-title":"OMICS"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0580","doi-asserted-by":"crossref","first-page":"12840","DOI":"10.1073\/pnas.220410397","article-title":"Amplification of dopaminergic signaling by a positive feedback loop","volume":"97","author":"Nishi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0585","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jpsychires.2011.06.013","article-title":"DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder","volume":"45","author":"Nohesara","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0590","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ajhg.2011.12.020","article-title":"DNA methylation signatures in development and aging of the human prefrontal cortex","volume":"90","author":"Numata","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0595","first-page":"12","article-title":"Sodium valproate as an adjunctive drug in treatment of schizophrenia","volume":"1","author":"Omranifard","year":"2007","journal-title":"IJPBS"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0600","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","article-title":"Schizophrenia","volume":"374","author":"van Os","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2012.03.006","article-title":"C19orf12 and FA2H mutations are rare in Italian patients with neurodegeneration with brain iron accumulation","author":"Panteghini","year":"2012","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0610","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.schres.2008.04.013","article-title":"Analysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia","volume":"102","author":"Pedrosa","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0615","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.2217\/14622416.9.12.1785","article-title":"Pharmacoepigenetics and pharmacoepigenomics","volume":"9","author":"Peedicayil","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0620","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of Valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0625","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/mp.2009.138","article-title":"Brain weight in males is correlated with DNA methylation at IGF2","volume":"15","author":"Pidsley","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0630","article-title":"Obtaining high quality RNA from single cell populations in human postmortem brain tissue","volume":"1444","author":"Pietersen","year":"2009","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0635","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/jnr.10173","article-title":"Differential expression of the \u201cC\u201d and \u201cT\u201d alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics","volume":"67","author":"Polesskaya","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0640","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1038\/tp.2013.73","article-title":"DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP","volume":"3","author":"Powell","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0645","doi-asserted-by":"crossref","first-page":"25","DOI":"10.31887\/DCNS.2010.12.1\/cptak","article-title":"Epigenetic approaches to psychiatric disorders","volume":"12","author":"Ptak","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0650","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2217\/epi.15.116","article-title":"Does DNA methylation influence the effects of psychiatric drugs?","volume":"8","author":"Reynolds","year":"2016","journal-title":"Epigenomics"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0655","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/schbul\/sbr150","article-title":"Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia","volume":"39","author":"Roffman","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0660","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ajmg.b.31062","article-title":"Analysis of whole genome biomarker expression in blood and brain","volume":"153B","author":"Rollins","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0665","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.conb.2009.05.011","article-title":"Regulation of chromatin structure in memory formation","volume":"19","author":"Roth","year":"2009","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0670","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S2215-0366(15)00553-2","article-title":"Polygenic overlap between schizophrenia risk and antipsychotic response: A genomic medicine approach","volume":"3","author":"Ruderfer","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0675","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/13102818.2014.933501","article-title":"Whole genome methylation analyses of schizophrenia patients before and after treatment","volume":"28","author":"Rukova","year":"2014","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0680","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0166-4328(01)00425-9","article-title":"Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder \u2014 the spontaneously hypertensive rat","volume":"130","author":"Russell","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0685","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.mp.4001954","article-title":"Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection","volume":"12","author":"Ruzicka","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0690","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamapsychiatry.2015.49","article-title":"Circuit- and diagnosis-specific dna methylation changes at \u03b3-aminobutyric acid\u2013related genes in postmortem human hippocampus in schizophrenia and bipolar disorder","volume":"72","author":"Ruzicka","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0695","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/tpj.2015.90","article-title":"The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis","volume":"17","author":"Sacchetti","year":"2017","journal-title":"Pharmacogenom. J."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0700","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.schres.2014.05.015","article-title":"Effect of antipsychotic drugs on gene expression in the prefrontal cortex and nucleus accumbens in the spontaneously hypertensive rat (SHR)","volume":"157","author":"Santoro","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0705","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1073\/pnas.0510310103","article-title":"A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters","volume":"103","author":"Saxonov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0710","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/syn.890010203","article-title":"Dopamine receptors and the dopamine hypothesis of schizophrenia","volume":"1","author":"Seeman","year":"1987","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0715","doi-asserted-by":"crossref","DOI":"10.1186\/1744-9081-2-37","article-title":"Haloperidol treatment induces tissue- and sex-specific changes in DNA methylation: a control study using rats","volume":"2","author":"Shimabukuro","year":"2006","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0720","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1089\/omi.2015.0121","article-title":"Esophageal cancer epigenomics and integrome analysis of genome-wide methylation and expression in high risk Northeast Indian population","volume":"19","author":"Singh","year":"2015","journal-title":"OMICS"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0725","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajmg.b.32278","article-title":"DNA extracted from saliva for methylation studies of psychiatric traits: evidence for tissue specificity and relatedness to brain","volume":"168","author":"Smith","year":"2015","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0730","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/341750","article-title":"Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia","volume":"71","author":"Straub","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0735","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pnpbp.2014.08.010","article-title":"Effects of quetiapine on DNA methylation in neuroblastoma cells","volume":"56","author":"Sugawara","year":"2015","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0740","doi-asserted-by":"crossref","unstructured":"Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L.M., Liu, D.R., Aravind, L., Rao, A., 2009. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science (80-.). 324, 930\u20135, https:\/\/doi.org\/10.1126\/science.1170116.","DOI":"10.1126\/science.1170116"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.005","article-title":"Schizophrenia, \u201cjust the facts\u201d 4. Clinical features and conceptualization","volume":"110","author":"Tandon","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2010.05.025","article-title":"Schizophrenia, \u201cjust the facts\u201d 5. Treatment and prevention. Past, present, and future","volume":"122","author":"Tandon","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0755","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1017\/S1461145713001442","article-title":"Methylation at a transcription factor-binding site on the 5-HT1A receptor gene correlates with negative symptom treatment response in first episode schizophrenia","volume":"17","author":"Tang","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0760","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/npp.2013.300","article-title":"Abnormal GABAergic function and negative affect in schizophrenia","volume":"39","author":"Taylor","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0765","doi-asserted-by":"crossref","first-page":"e1001046","DOI":"10.1371\/journal.pbio.1001046","article-title":"A User's guide to the encyclopedia of DNA elements (ENCODE)","volume":"9","author":"The ENCODE Project Consortium","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0770","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1517\/14622416.3.3.299","article-title":"Pharmacogenetics and folate metabolism -- a promising direction","volume":"3","author":"Ulrich","year":"2002","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0775","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.euroneuro.2012.01.006","article-title":"Clinical response to antipsychotic drug treatment: association study of polymorphisms in six candidate genes","volume":"22","author":"Vehof","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0780","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1073\/pnas.2637013100","article-title":"DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains","volume":"101","author":"Veldic","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0785","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1073\/pnas.0409665102","article-title":"In psychosis, cortical interneurons overexpress DNA-methyltransferase 1","volume":"102","author":"Veldic","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0790","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw373","article-title":"Schizophrenia-associated methylomic variation: molecular signatures of disease and polygenic risk burden across multiple brain regions","author":"Viana","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0795","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/ijo.2008.100","article-title":"Methyl donor supplementation prevents transgenerational amplification of obesity","volume":"32","author":"Waterland","year":"2008","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0800","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1038\/tp.2013.111","article-title":"Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients","volume":"4","author":"Wockner","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0805","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ajp.2016.02.002","article-title":"Role of MTHFR C677T gene polymorphism in the susceptibility of schizophrenia: An updated meta-analysis","volume":"20","author":"Yadav","year":"2016","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0810","series-title":"Gene Methylation Patterns and Expression BT - DNA Methylation: Molecular Biology and Biological Significance","first-page":"523","author":"Yeivin","year":"1993"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0815","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/0269881114562090","article-title":"\u201cFirst do no harm.\u201d A systematic review of the prevalence and management of antipsychotic adverse effects","volume":"29","author":"Young","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0820","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/sj.mp.4002023","article-title":"Meta-analysis of two dopamine D2 receptor gene polymorphisms with tardive dyskinesia in schizophrenia patients","volume":"12","author":"Zai","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0825","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1517\/17425255.2013.736964","article-title":"Pharmacogenetics of antipsychotics: recent progress and methodological issues","volume":"9","author":"Zhang","year":"2013","journal-title":"Expert Opin. Drug Metab."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0830","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ajhg.2010.02.005","article-title":"Genetic control of individual differences in gene-specific methylation in human brain","volume":"86","author":"Zhang","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0835","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1017\/S1461145712001277","article-title":"Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis","volume":"16","author":"Zhang","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0840","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.schres.2009.03.020","article-title":"An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes","volume":"111","author":"Zhubi","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2017.10.004_bb0845","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/carcin\/18.5.869","article-title":"Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis","volume":"18","author":"Zingg","year":"1997","journal-title":"Carcinogenesis"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617305584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617305584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T14:35:53Z","timestamp":1719498953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584617305584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":165,"alternative-id":["S0278584617305584"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.10.004","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA methylation and antipsychotic treatment mechanisms in schizophrenia: Progress and future directions","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}